A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, scientists have found. The discovery has important implications for preventing severe COVID-19.

Study investigated whether SARS-CoV-2 lingers in tissues after COVID-19 recovery and if it's linked to long COVID symptoms.

Coronavirus survivors have twice the risk of developing dangerous blood clots that can travel to their lungs compared to people who haven’t been infected, as well double the chance of ...

The lungs are using the same sensors ... Simple Blood Test Could Predict Risk of Long-Term COVID-19 Lung Problems Mar. 15, 2024 — Researchers have discovered a potential way to predict which ...

No matter how implausible it is or how weak the evidence for it is, the myth that COVID vaccines cause "turbo cancer" just ...

According to a new report published by Allied Market Research, titled, “Lung Injury Market by Application, Technology, and end user: global opportunity analysis and industry forecast, 2021–2030,” the ...

A quarter of people had Covid-19 viral proteins in their blood up to 14 months after infection. These proteins in the blood ...

ICS treatment did not have a significant impact on symptom management of post-COVID-19 chronic cough; however, it can improve impaired lung function in these individuals. Follow-up involved patient ...

The American Lung Association's 25th annual State of the Air report reveals significant disparities in air quality, with ...

BIO 300 use led to reduced levels of a proinflammatory/profibrotic cytokine associated with lung injury from radiation ...

With winter approaching, here's what to know about this season's flu, respiratory infections and the lingering presence of ...

The number of Scottish veterans who were hospitalised with COVID-19 or who died from the disease was no greater than in the wider community, according to new research published today.